Skip to content

Contrast enhanced Ultra-low-field-MRI in CNS infalmmation and brain tumors

Contrast enhanced Ultra-low-field-MRI in CNS infalmmation and brain tumors - ULF-MRI

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00038574
Enrollment
120
Registered
2026-03-04
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory disaeses of the brain, brain tumors

Interventions

Group 1: Native and contrast enhanced Ultra-low-filed-MRI of the brain, standard-MRI is performed independent from this study as part of standard clinical care

Sponsors

Klinik für Neurologie, Universitätsklinik Aachen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Age over 18 years • Capacity to give informed consent • Suspected or confirmed cerebral mass lesion or inflammation of the brain • Medical indication for performing a high-field MRI with contrast agent

Exclusion criteria

Exclusion criteria: • Contraindication to undergoing MRI (e.g., pacemaker) • Severe claustrophobia that makes MRI examination impossible • Pregnancy or breastfeeding • Orthopedic conditions that do not allow prolonged lying down for the MRI examination • Severe renal impairment • Known hypersensitivity to gadolinium-based MRI contrast agents

Design outcomes

Primary

MeasureTime frame
Number of contrast enhancing and non-enhancing lesions on ultra-lowfield-MRI compared to standard MRI in percent. Checked after completion of the study.

Secondary

MeasureTime frame
Volume of contrast enhancing and non-enhancing lesions on ultra-lowfield-MRI compared to standard MRI in percent. Checked after completion of the study.

Countries

Germany

Contacts

Public ContactFlorian Holtbernd

Klinik für Neurologie Universitätsklinik Aachen

fholtbernd@ukaachen.de+49241800

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026